The record

The patent family.

The documents as supplied, rather than a summary of them.

The kiwifruit research associated with Genactin® sits behind a granted patent family. Read the proprietor and inventor lines directly.

The patent record

These are the documents as supplied — read the proprietor and inventor lines rather than any summary of them.

European patent specification EP 2 648 741 B1
EP 2 648 741 B1 — “Cardio-protective agents from kiwifruit”. Proprietor: University of Oslo. Inventor: A. K. Duttaroy. View the official record ↗
United States patent application publication US 2014/0314989 A1
US 2014/0314989 A1 — “Cardio-protective agents from kiwifruit”, application publication. Inventor: Asim Kanti Duttaroy. View the official record ↗

A patent describes an invention and its claims. It is not a clinical result, and it is not a statement about what any finished product does in a person. Research on kiwifruit or kiwi fruit extract is not presented here as a clinical trial of a Genimen product.

The research behind it.

The studies, their design and what each one actually measured.